Colon cancer cells exposed to 5-fluorouracil-based anti-cancer therapy display elevated expression of PUMA and BIM and high induction of these proteins is correlated with a better prognosis of the patients [180]. The gene discussed is BCL2L11; the disease is malignant colon neoplasm.